Comparison of continuous-flow and pulsatile-flow blood pumps on reducing pulmonary artery pressure in patients with fixed pulmonary hypertension

Artificial Organs

Volumn 37, Issue 9, 2013, Pages 763-767

  Ozturk, Pelin ^a   Engin, Aysen Yaprak ^a   Nalbantgil, Sanem ^a   Oguz, Emrah ^a   Ayik, Fatih ^a   Engin, Cagatay ^a   Yagdi, Tahir ^a   Erkul, Sinan ^a   Balcioglu, Ozlem ^a   Ozbaran, Mustafa ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Heart failure; Left ventricular assist device; Pulmonary artery pressure; Pulmonary hypertension

Indexed keywords

BLOOD; BLOOD PRESSURE; CARDIOLOGY; CARDIOVASCULAR SURGERY; FAILURE (MECHANICAL); FIBER OPTIC SENSORS; HEART; HEMODYNAMICS; PULSATILE FLOW;

ARTERY PRESSURE; BLOOD PUMP; CONTINUOUS FLOW PUMPS; CONTINUOUS-FLOW; HEART FAILURE; HEART TRANSPLANTATION; PULMONARY ARTERY; PULMONARY ARTERY PRESSURE; PULMONARY HYPERTENSION; RIGHT VENTRICULAR;

LEFT VENTRICULAR ASSIST DEVICES;

ADULT; ARTICLE; ASSISTED CIRCULATION; BLOOD PUMP; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTINUOUS FLOW BLOOD PUMP; CONTROLLED STUDY; DISEASE SEVERITY; HEART EJECTION FRACTION; HEART FAILURE; HEART MOVEMENT; HUMAN; IMPLANTATION; INTERMETHOD COMPARISON; LEFT VENTRICULAR ASSIST DEVICE; LUNG ARTERY PRESSURE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULSATILE FLOW; PULSATILE FLOW BLOOD PUMP; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; TRICUSPID VALVE REGURGITATION;

HEART FAILURE; LEFT VENTRICULAR ASSIST DEVICE; PULMONARY ARTERY PRESSURE; PULMONARY HYPERTENSION;

ADULT; BLOOD PRESSURE; FEMALE; HEART FAILURE; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PULMONARY ARTERY; RETROSPECTIVE STUDIES;

EID: 84890859266     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/aor.12164     Document Type: Article

References (17)

1. Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC); European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT), Galiè N, Hoeper MM, Humbert M, etal. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009;34:1219-1263.
2. Costard-Jäckle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 1992;19:48-54.
3. Erickson KW, Costanzo-Nordin MR, O'Sullivan EJ, etal. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. J Heart Transplant 1990;9:526-537.
4. Goland S, Czer LS, Kass RM, etal. Pre-existing pulmonary hypertension in patients with end-stage heart failure: impact on clinical outcome and hemodynamic follow-up after orthotopic heart transplantation. J Heart Lung Transplant 2007;26:312-318.
5. Gude E, Simonsen S, Geiran OR, etal. Pulmonary hypertension in heart transplantation: discrepant prognostic impact of pre-operative compared with 1-year post-operative right heart hemodynamics. J Heart Lung Transplant 2010;29:216-223.
6. Pauwaa S, Bhat G, Tatooles AJ, etal. How effective are continuous flow left ventricular assist devices in lowering high pulmonary artery pressures in heart transplant candidates? Cardiol J 2012;19:153-158.
7. Etz CD, Welp HA, Tjan TD, etal. Medically refractory pulmonary hypertension treatment with nonpulsatile left ventricular assist devices. Ann Thorac Surg 2007;83:1697-1705.
8. Salzberg SP, Lachat ML, von Harbou K, Zünd G, Turina MI. Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates. Eur J Cardiothorac Surg 2005;27:222-225.
9. Nair PK, Kormos RL, Teuteberg JJ, etal. Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension. J Heart Lung Transplant 2010;29:201-208.
10. Liden H, Haraldsson A, Ricksten SE, Kjellman U, Wiklund L. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance? Eur J Cardiothorac Surg 2009;35:1029-1034.
11. Martin J, Siegenthaler MP, Friesewinkel O, etal. Implantable left ventricular assist device for treatment of pulmonary hypertension for orthotopic heart transplantation-a preliminary study. Eur J Cardiothorac Surg 2004;25:971-977.
12. Zimpfer D, Zrunek P, Sandner S, etal. Post-transplant survival a fter lowering fixed pulmonary hypertension using left ventricular assist devices. Eur J Cardiothorac Surg 2007;31:698-702.
13. Mikus E, Stapanenko A, Krabatsch T, etal. Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients. Eur J Cardiothorac Surg 2011;40:971-977.
14. Hertz MI, Aurora P, Christie JD, etal. Scientific registry of the International Society for Heart and Lung Transplantation: introduction to the 2010 annual reports. J Heart Lung Transplant 2010;29:1083-1088.
15. von Scheidt W, Costard-Jaeckle A, Stempfle HU, etal. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study. J Heart Lung Transplant 2006;25:1070-1076.
16. Freitas AF Jr, Bacal F, Oliveira Júnior Jde L, etal. Sildenafil vs. sodium before nitroprusside for the pulmonary hypertension reversibility test before cardiac transplantation. Arq Bras Cardiol 2012;99:848-856.
17. Sablotzki A, Hentschel T, Hofmann S, Simm A, Mühling J, Czeslick E. Inhaled aerosolized iloprost in the evaluation of heart transplant candidates-experiences with 45 cases. J Clin Anesth 2006;18:108-113.